In the first part of his Pharma Commerce video interview, Arthur Axelrad, co-founder and CEO of Dispatch Science, discusses ...
Haub School of Business, shares why wholesalers remain indispensable to pharmaceutical distribution—supporting cold chain ...
Samsung Biologics acquires Human Genome Sciences from GSK for $280 million, expanding its US manufacturing footprint. The ...
In the first part of her Pharma Commerce video interview, Tina Martinez, vice president and head of global products and ...
In today’s Pharma Pulse, Novo Nordisk secures a landmark approval for a weight-loss pill, while Yusen Logistics expands its ...
Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment ...
In today’s Pharma Pulse, major pharma players commit to most-favored-nation pricing, as DHL bolsters West Coast logistics for ...
In today’s Pharma Pulse, Samsung Biologics enters the US market with a $280 million site acquisition, AstraZeneca secures a ...
Yusen Logistics (Europe), an overseas subsidiary of Yusen Logistics Group, has officially completed the purchase of the ...
Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business, describes why uncertainty around final tariff rules is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results